News and Trends 18 Dec 2017
British Biotech Takes Over Development of Gene Therapy for Rare Immune Disease
Orchard Therapeutics has licensed a gene therapy for the rare genetic disorder X-linked chronic granulomatous disease (X-CGD) from the non-profit Généthon. …
